Suppr超能文献

[小儿B细胞急性淋巴细胞白血病拷贝数改变的研究进展]

[Research progress on copy number alterations in pediatric B-cell acute lymphoblastic leukemia].

作者信息

Xu Xi-Yuan, Hu Qun

机构信息

Department of Pediatric Hematology and Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jun 15;27(6):746-752. doi: 10.7499/j.issn.1008-8830.2501007.

Abstract

Copy number alteration (CNA) is a significant genetic change in pediatric B-cell acute lymphoblastic leukemia (B-ALL), with deletions, deletions, and deletions being the most common. Recent studies have increasingly highlighted the potential prognostic significance of these gene deletions and multiple co-deletions in pediatric B-ALL. This paper reviews the main detection methods for CNA, as well as the prognostic characteristics and treatment approaches for common CNA in pediatric B-ALL.

摘要

拷贝数改变(CNA)是小儿B细胞急性淋巴细胞白血病(B-ALL)中一种重要的基因变化,其中缺失、缺失和缺失最为常见。最近的研究越来越多地强调了这些基因缺失和多重共缺失在小儿B-ALL中的潜在预后意义。本文综述了CNA的主要检测方法,以及小儿B-ALL中常见CNA的预后特征和治疗方法。

相似文献

1
[Research progress on copy number alterations in pediatric B-cell acute lymphoblastic leukemia].
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jun 15;27(6):746-752. doi: 10.7499/j.issn.1008-8830.2501007.
5
The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
Cytogenet Genome Res. 2016;150(3-4):242-252. doi: 10.1159/000456572. Epub 2017 Feb 18.
6
Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
Int J Hematol. 2018 Sep;108(3):312-318. doi: 10.1007/s12185-018-2474-7. Epub 2018 May 21.
9
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
Haematologica. 2013 Jul;98(7):1081-8. doi: 10.3324/haematol.2013.085175. Epub 2013 Mar 18.
10

本文引用的文献

1
A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia.
Ann Med. 2024 Dec;56(1):2427365. doi: 10.1080/07853890.2024.2427365. Epub 2024 Nov 18.
3
[Current situation and prospect of diagnosis and therapy of childhood acute leukemia in China].
Zhonghua Yi Xue Za Zhi. 2024 Jul 16;104(27):2477-2482. doi: 10.3760/cma.j.cn112137-20231211-01347.
4
Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study.
Eur J Haematol. 2024 Sep;113(3):357-370. doi: 10.1111/ejh.14245. Epub 2024 Jun 7.
5
is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.
Front Oncol. 2024 Apr 3;14:1337954. doi: 10.3389/fonc.2024.1337954. eCollection 2024.
7
Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1 and Day 15 MRD positivity.
Br J Haematol. 2024 Apr;204(4):1344-1353. doi: 10.1111/bjh.19338. Epub 2024 Mar 13.
8
EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms.
Front Immunol. 2024 Jan 22;15:1320689. doi: 10.3389/fimmu.2024.1320689. eCollection 2024.
9
Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia.
Biomedicines. 2024 Jan 1;12(1):89. doi: 10.3390/biomedicines12010089.
10
Association of deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.
Blood Cell Ther. 2023 Jul 21;6(3):80-86. doi: 10.31547/bct-2023-004. eCollection 2023 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验